Barriers to accessibility of medicines for hyperlipidemia in low- and middle-income countries
Saved in:
Main Authors: | Chaoyang Li (Author), Garrison Spencer (Author), Muhammad Jami Husain (Author), Rachel Nugent (Author), Deon Auzenne (Author), Deliana Kostova (Author), Patricia Richter (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Barriers to accessibility of medicines for hyperlipidemia in low- and middle-income countries.
by: Chaoyang Li, et al.
Published: (2024) -
The Cost-Effectiveness of Hyperlipidemia Medication in Low- and Middle-Income Countries: A Review
by: Muhammad Jami Husain, et al.
Published: (2022) -
Building the health-economic case for scaling up the WHO-HEARTS hypertension control package in low- and middle-income countries
by: Andrew E. Moran, et al.
Published: (2022) -
Barriers to effective pharmacy practice in low- and middle-income countries
by: Babar ZU, et al.
Published: (2014) -
Expanding choice and access in contraception: an assessment of intrauterine contraception policies in low and middle-income countries
by: Moazzam Ali, et al.
Published: (2019)